Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid

References

• Corvec S, Portillo ME, Pasticci BM, et al. Epidemiology and new developments in the diagnosis of prosthetic joint infection. Int J Artif Organs. 2012;35:923–934.
   PubMed Web of Science ®Google Scholar
• Aubin GG, Lavigne J-P, Guyomarch B, et al. Staphylokinase and ABO group phenotype: new players in Staphylococcus aureus implant-associated infection development. Future Microbiol. 2015;10:1929–1938.
   PubMed Web of Science ®Google Scholar
• Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785.
   PubMed Web of Science ®Google Scholar
• Wright JA, Nair SP. Interaction of staphylococci with bone. Int J Med Microbiol. 2010;300:193–204.
   PubMed Web of Science ®Google Scholar
• Tong SYC, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661.
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–1654.
   PubMed Web of Science ®Google Scholar
• Wu W-S, Chen C-C, Chuang Y-C, et al. Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. J Microbiol Immunol Infect. 2013;46:89–95.
   PubMedGoogle Scholar
• Peel TN, Cole NC, Dylla BL, et al. Matrix-assisted laser desorption ionization time of flight mass spectrometry and diagnostic testing for prosthetic joint infection in the clinical microbiology laboratory. Diagn Microbiol Infect Dis. 2015;81:163–168.
   PubMed Web of Science ®Google Scholar
• Bémer P, Plouzeau C, Tande D, et al. Evaluation of 16S rRNA gene PCR sensitivity and specificity for diagnosis of prosthetic joint infection: a prospective multicenter cross-sectional study. J Clin Microbiol. 2014;52:3583–3589.
   PubMed Web of Science ®Google Scholar
• Lepelletier D, Corvec S, Caillon J, et al. Eradication of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit: which measures for which success? Am J Infect Control. 2009;37:195–200.
   PubMed Web of Science ®Google Scholar
• Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239.
   PubMed Web of Science ®Google Scholar
• Aubin GG, Lepelletier D, Reynaud A, et al. Methicillin-susceptible Staphylococcus aureus CC398: first description in prosthetic joint infection and genetic background comparison with nasal carriage isolates. J Infect Chemother. 2014;20:394–396.
   PubMed Web of Science ®Google Scholar
• Wichelhaus TA, Schäfer V, Brade V, et al. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43:2813–2816.
   PubMed Web of Science ®Google Scholar
• Farrell DJ, Castanheira M, Chopra I. Characterization of global patterns and the genetics of fusidic acid resistance. Clin Infect Dis. 2011;52:S487–S492.
   PubMed Web of Science ®Google Scholar
• Croes S, Deurenberg RH, Boumans M-LL, et al. Staphylococcus aureus biofilm formation at the physiologic glucose concentration depends on the S. aureus lineage. BMC Microbiol. 2009;9:229.
   PubMed Web of Science ®Google Scholar
• Furustrand Tafin U, Trampuz A, Corvec S. In vitro emergence of rifampicin resistance in Propionibacterium acnes and molecular characterization of mutations in the rpoB gene. J Antimicrob Chemother. 2013;68:523–528.
   PubMed Web of Science ®Google Scholar
• Furustrand Tafin U, Aubin GG, Eich G, et al. Occurrence and new mutations involved in rifampicin-resistant Propionibacterium acnes strains isolated from biofilm or device-related infections. Anaerobe. 2015;34:116–119.
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-body infection (FBI) study group. JAMA. 1998;279:1537–1541.
   PubMed Web of Science ®Google Scholar
• Steffee CH, Morrell RM, Wasilauskas BL. Clinical use of rifampicin during routine reporting of rifampicin susceptibilities: a lesson in selective reporting of antimicrobial susceptibility data. J Antimicrob Chemother. 1997;40:595–598.
   PubMed Web of Science ®Google Scholar
• Valour F, Trouillet-Assant S, Riffard N, et al. Antimicrobial activity against intraosteoblastic Staphylococcus aureus. Antimicrob Agents Chemother. 2015;59:2029–2036.
   PubMed Web of Science ®Google Scholar
• Chuard C, Lucet JC, Rohner P, et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis. 1991;163:1369–1373.
   PubMed Web of Science ®Google Scholar
• Zeller V, Desplaces N. Antibiotherapy of bone and joint infections. Rev Rhum. 2006;73:183–190.
   Google Scholar
• Cluzel RA, Lopitaux R, Sirot J, et al. Rifampicin in the treatment of osteoarticular infections due to staphylococci. J Antimicrob Chemother. 1984;13:23–29.
   PubMed Web of Science ®Google Scholar
• Klein S, Nurjadi D, Eigenbrod T, et al. Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid? Int J Antimicrob Agents. 2016;47:155–157.
   PubMed Web of Science ®Google Scholar
• Lim K-T, Teh CSJ, Yusof MYM, et al. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia. Trans R Soc Trop Med Hyg. 2014;108:112–118.
   PubMed Web of Science ®Google Scholar
• Daurel C, Prunier A-L, Chau F, et al. Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus. FEMS Immunol Med Microbiol. 2007;51:344–349.
   PubMedGoogle Scholar
• Drancourt M, Stein A, Argenson JN, et al. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother. 1997;39:235–240.
   PubMed Web of Science ®Google Scholar
• Jensen K. Methicillin-resistant staphylococci. Lancet. 1968;2:1078.
   PubMed Web of Science ®Google Scholar